Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEXO.L Regulatory News (EXO)

  • There is currently no data for EXO

Trading Statement

11 Nov 2015 07:00

RNS Number : 2597F
Exova Group PLC
11 November 2015
Β 

11 November 2015

Exova Group plc

Trading Update

Organic growth on track and acquisitions performing to planΒ 

Exova Group plc ("Exova"), a leading international provider of technically demanding testing, certification and advisory services, today releases a Trading Update for the period since 30 June 2015 to date. Where stated, financial results are for the period from 1 January to 31 October 2015 compared with the corresponding period in 2014.

Group performance for the ten months to 31 October 2015

Β 

Β· Revenue up 9.3% at constant currency; 7.5% at actual rates

o 2.7% organic growth at constant currency (7.6% excluding Oil & Gas and Industrials)

o 6.6% growth from M&A activity

Β· BM TRADA acquisition integrating well and performing in line with expectations

Β· M&A pipeline continues to be strong

Β· Outlook for 2015 earnings remains unchanged

Regional performance in the period from 1 July 2015 to date

Β 

In Europe, we saw good organic growth in our Health Sciences and Product & Certification clusters. The integration of BM TRADA, which we acquired in May this year, has gone well and the business is on track to deliver in line with expectations for 2015 and to realise the planned synergies in 2016. As expected, the impact of low oil prices has led to further contraction and price pressure in our Oil & Gas and Industrials cluster.

Organic revenues in the Americas have improved as we continued to see good progress in the Aerospace and Transportation sectors. Our Oil & Gas and Industrials cluster has experienced similar headwinds to Europe.

Β 

In Rest of World, strong growth has continued in the Middle East and the pipeline of new contracts looks strong into 2016.

We have continued to take restructuring actions across the Group to mitigate the impact on margin where we face market headwinds.

Outlook

Β 

The Board confirms previous guidance for full year earnings in 2015. Restructuring costs will also be in line with expectations.

Β 

Ian El-Mokadem, Chief Executive Officer, commented:

Β 

"I am pleased with our overall performance for the year to date. We have seen good growth in most of our sectors and are making very good progress with acquisitions."

Β 

Full year results

The Group's full year results to 31 December 2015 will be announced on 2 March 2016.

Β 

Contacts

Β 

Ian Middleton / Sophie Moate

Powerscourt Group

Tel. Direct +44 (0)20 7250 1446 / +44 (0)7885 508 527

exova@powerscourt-group.com

Β 

Ian Power, Investor Relations

Exova Group plc

Telephone: +44 (0) 131 476 7619

investor.relations@exova.com

Β 

Β 

About Exova

Exova is one of the world's leading laboratory-based testing groups, trusted by organisations to test and advise on the safety, quality and performance of their products and operations. Headquartered in Edinburgh, UK Exova operates 143Β laboratories and offices in 32 countries and employs around 4,500 people throughout Europe, the Americas, the Middle East and Asia/Asia Pacific.

Exova's capabilities help to extend asset life, bring predictability to applications, and shorten the time to market for customers' products, processes and materials. With over 90 years' experience, Exova specialises in testing across a number of key sectors from health sciences to aerospace, transportation, oil and gas, fire and construction.

This Trading Update release contains forward-looking statements that involve substantial risks and uncertainties and actual results and developments may differ materially from those expressed or implied by these statements by a variety of factors. These forward-looking statements speak only as at the date of this press release. In addition, all projections, valuations and statistical analyses provided in this document may be based on unaudited pro-forma financial information, subjective assessments and assumptions. They may use alternative methodologies that produce different results and should not be relied upon as an accurate prediction of future performance.

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTPKKDNOBDDQDD
Date   Source Headline
15th Feb 20169:00 amRNSExova acquires majority stake in Admaterials
10th Feb 20164:35 pmRNSPrice Monitoring Extension
15th Jan 20167:00 amRNSTrading Statement
31st Dec 201512:35 pmRNSPrice Monitoring Extension
31st Dec 20159:00 amRNSNotification of Transactions of Directors & PDMRs
18th Dec 201512:16 pmRNSAppointment of Senior Independent Director
9th Dec 20153:18 pmRNSChange of financial results date
8th Dec 201510:35 amRNSDirector/PDMR Shareholding
30th Nov 20157:00 amRNSAppointment of Chief Financial Officer
11th Nov 20157:00 amRNSTrading Statement
4th Nov 201510:30 amRNSExova appoints Paul Barry as MD for Europe
3rd Nov 201511:14 amRNSNotification of transactions of Directors & PDMRs
21st Oct 20159:18 amRNSDirector/PDMR Shareholding
19th Oct 201511:51 amRNSDirector/PDMR Shareholding
13th Oct 20152:00 pmRNSExova opens Pittsburgh laboratory
5th Oct 201510:00 amRNSExova wins Qatar testing contract
2nd Oct 20159:04 amRNSNotification of transactions of Directors & PDMRs
1st Oct 201510:00 amRNSExova appoints managing director for MEAAP region
28th Sep 20157:00 amRNSAppointment of Chief Financial Officer
10th Sep 201510:23 amRNSDirector/PDMR Shareholding
8th Sep 201510:50 amRNSDirector Declaration
7th Sep 20159:30 amRNSDirector/PDMR Shareholding
1st Sep 201510:57 amRNSExova wins UAE outsourcing deal
28th Aug 20157:01 amRNSDirectorate Change
28th Aug 20157:00 amRNSHalf Yearly Report
6th Aug 20159:11 amRNSTR-1: Notification of Major Interest in Shares
29th Jul 201511:00 amRNSExova wins long term agreement
22nd Jul 201510:00 amRNSExova opens new Malaysia lab
7th Jul 201510:00 amRNSExova extends relationship with Maersk Oil
2nd Jul 20154:40 pmRNSSecond Price Monitoring Extn
2nd Jul 20154:35 pmRNSPrice Monitoring Extension
24th Jun 20151:40 pmRNSDirector/PDMR Shareholding
23rd Jun 20151:33 pmRNSDirector/PDMR Shareholding
17th Jun 20152:50 pmRNSDirector/PDMR Shareholding
9th Jun 201511:00 amRNSExova lands Kaombo Project contract
8th Jun 20152:10 pmRNSDirector/PDMR Shareholding
19th May 201512:20 pmRNSDirector/PDMR Shareholding
14th May 20154:52 pmRNSResult of AGM
14th May 20157:00 amRNSTrading Statement
20th Apr 201512:50 pmRNSExova wins contract with AGDC
20th Apr 20157:00 amRNSChange of Adviser
10th Apr 20159:46 amRNSAnnual Financial Report
16th Mar 20153:05 pmRNSDirector/PDMR Shareholding
4th Mar 20157:00 amRNSFinal Results
24th Feb 201512:55 pmRNSTR-1: Notification of Major Interest in Shares
23rd Feb 20159:00 amRNSExova wins long term agreement with Böhler
9th Feb 201510:00 amRNSExova acquires Environmental Evaluation
4th Feb 201510:30 amRNSExova agrees calibration outsourcing deal
2nd Feb 20157:00 amRNSExova contract wins for testing on Doha Metro
22nd Jan 20159:20 amRNSNotification of New Directorship

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.